| NXG | VDE | NXG / VDE | |
| Gain YTD | 33.861 | 20.275 | 167% |
| Net Assets | 442M | 11.8B | 4% |
| Total Expense Ratio | 2.77 | 0.09 | 3,078% |
| Turnover | 76.39 | 11.00 | 694% |
| Yield | 0.00 | 2.68 | - |
| Fund Existence | 14 years | 22 years | - |
| NXG | VDE | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 82% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 89% | 3 days ago 83% |
| MACD ODDS (%) | 3 days ago 90% | 6 days ago 81% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 81% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 80% |
| Advances ODDS (%) | 5 days ago 90% | 12 days ago 90% |
| Declines ODDS (%) | 3 days ago 85% | 4 days ago 82% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 83% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSMEX | 48.46 | 0.81 | +1.70% |
| Fidelity Select Medical Tech and Devcs | |||
| VKSRX | 18.87 | 0.18 | +0.96% |
| Virtus KAR Small-Mid Cap Core R6 | |||
| CFLGX | 26.58 | 0.21 | +0.80% |
| ClearBridge Tactical Dividend Income A | |||
| RTSGX | 5.87 | -0.09 | -1.51% |
| Transamerica Small Cap Growth R6 | |||
| JGRJX | 38.40 | -0.68 | -1.74% |
| JPMorgan Growth Advantage R2 | |||
A.I.dvisor tells us that NXG and ET have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXG and ET's prices will move in lockstep.